Healthcare provider profile · identity verified

Christopher Peoples, M.D.

Family Practice · TACOMA, WA · NPI 1205198959

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	510	161
Losartan Potassium	Losartan Potassium	322	96
Amlodipine Besylate	Amlodipine Besylate	314	101
Levothyroxine Sodium	Levothyroxine Sodium	275	81
Lisinopril	Lisinopril	220	66
Gabapentin	Gabapentin	192	61
Metformin Hcl	Metformin Hcl	161	48
Metoprolol Succinate	Metoprolol Succinate	149	50
Omeprazole	Omeprazole	149	42
Alendronate Sodium	Alendronate Sodium	142	35
Trazodone Hcl	Trazodone Hcl	131	41
Pantoprazole Sodium	Pantoprazole Sodium	123	29
Albuterol Sulfate Hfa	Albuterol Sulfate	121	42
Rosuvastatin Calcium	Rosuvastatin Calcium	111	40
Eliquis	Apixaban	106	22
Sertraline Hcl	Sertraline Hcl	101	31
Duloxetine Hcl	Duloxetine Hcl	90	26
Simvastatin	Simvastatin	87	25
Hydrochlorothiazide	Hydrochlorothiazide	86	26
Metoprolol Tartrate	Metoprolol Tartrate	79	21
Tamsulosin Hcl	Tamsulosin Hcl	79	34
Furosemide	Furosemide	74	23
Jardiance	Empagliflozin	68	19
Metformin Hcl Er	Metformin Hcl	65	21
Xarelto	Rivaroxaban	64	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	15
Fluoxetine Hcl	Fluoxetine Hcl	62	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	19
Allopurinol	Allopurinol	60	18
Famotidine	Famotidine	60	20
Mirtazapine	Mirtazapine	59	18
Buspirone Hcl	Buspirone Hcl	50	15
Bupropion Xl	Bupropion Hcl	49	14
Escitalopram Oxalate	Escitalopram Oxalate	49	14
Ozempic	Semaglutide	49	16
Warfarin Sodium	Warfarin Sodium	49	suppressed
Atenolol	Atenolol	48	12
Citalopram Hbr	Citalopram Hydrobromide	47	14
Bupropion Hcl Sr	Bupropion Hcl	46	17
Hydroxyzine Hcl	Hydroxyzine Hcl	46	14
Carvedilol	Carvedilol	45	17
Clopidogrel	Clopidogrel Bisulfate	45	14
Glipizide	Glipizide	44	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	12
Finasteride	Finasteride	41	suppressed
Montelukast Sodium	Montelukast Sodium	41	14
Pravastatin Sodium	Pravastatin Sodium	41	11
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	11
Potassium Chloride	Potassium Chloride	34	suppressed
Acyclovir	Acyclovir	33	11
Estradiol	Estradiol	32	suppressed
Lamotrigine	Lamotrigine	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Baclofen	Baclofen	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	11
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	14
Ondansetron Odt	Ondansetron	24	13
Aripiprazole	Aripiprazole	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Nitroglycerin	Nitroglycerin	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Metronidazole	Metronidazole	19	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Fluconazole	Fluconazole	16	11
Spironolactone	Spironolactone	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Ingrezza	Valbenazine Tosylate	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Prednisone	Prednisone	15	11
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Belsomra	Suvorexant	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lorazepam	Lorazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error